Navigating the quantum leap

: strategic approaches for pharmaceutical companies in a competitive R&D environment

Abstract

Access to health and medicine are human rights guaranteed by international organizations and a pivotal theme within the Sustainable Development Goals of the United Nations. However, drug shortages are a reality that affects millions worldwide due to inefficiency in Research & Development regarding the pharmaceutical industry. Quantum computing is rising as a solution to faster drug discovery, although guidelines for its strategic implementation by pharma companies in a competitive scenario are lacking. Considering this issue, this thesis applies a mixed-method approach to uncover the current state of quantum computing integration via a SWOT Analysis and evaluate whether investing in it is a viable strategy based on game theory. This study reveals different levels of quantum computing implementation among top pharmaceutical companies. Moreover, it was shown that if the first mover advantage is very high, then it is more likely that other companies will also invest. This research suggests that pharma companies should adapt to quantum computing technology based on company size. Larger companies may benefit from quantum computing investment by its better capabilities to adapt to market conditions, while smaller companies should build dynamic capabilities or niche applications, which will give them an advantage in specific areas and thus competitive strength.

Date of Award	31 Oct 2024
Original language	English
Awarding Institution	Universidade Católica Portuguesa
Supervisor	Peter V. Rajsingh (Supervisor)